Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole vs Danazol for endometriosis pain
NCT07183787Phase 2
Key facts
- Status
- Completed
- Start
- Apr 2019
- Primary completion
- Oct 2019
- Countries
- 1
- Modality
- Orthosteric Ligands
- Drugs
- letrozole
- Conditions
- endometriosis
01
Overview
Phase 2, randomised, open-label trial of letrozole in endometriosis. Primary endpoint: Change in pelvic pain severity at 12 weeks. Started Apr 2019; status: completed.
02
Design
- Study design
- RandomizedOpen-label
03
Who it enrols
Women aged 18-45 with surgically or clinically diagnosed endometriosis and moderate to severe pelvic pain (NRS >= 4).
04
Endpoints
Primary
Change in pelvic pain severity
Beyond the preview
Go deeper on NCT07183787.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07183787.